<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">68481</article-id><article-id pub-id-type="doi">10.7554/eLife.68481</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-217304"><name><surname>Zhang</surname><given-names>Yixiao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-208845"><name><surname>Sun</surname><given-names>Lisha</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4095-5026</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-268141"><name><surname>Li</surname><given-names>Haonan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217307"><name><surname>Ai</surname><given-names>Liping</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217305"><name><surname>Ma</surname><given-names>Qingtian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217303"><name><surname>Qiao</surname><given-names>Xinbo</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6759-921X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217306"><name><surname>Yang</surname><given-names>Jie</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217310"><name><surname>Zhang</surname><given-names>Hao</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231377"><name><surname>Ou</surname><given-names>Xunyan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231378"><name><surname>Wang</surname><given-names>Yining</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217309"><name><surname>Chen</surname><given-names>Guanglei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217308"><name><surname>Xue</surname><given-names>Jinqi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231379"><name><surname>Zhu</surname><given-names>Xudong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221137"><name><surname>Zhao</surname><given-names>Yu</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-217314"><name><surname>Yang</surname><given-names>Yongliang</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-156274"><name><surname>Liu</surname><given-names>Caigang</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3729-2839</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><institution content-type="dept">Department of Oncology</institution>, <institution>Shengjing Hospital of China Medical University</institution>, <addr-line><named-content content-type="city">Shenyang</named-content></addr-line>, <country>China</country></aff><aff id="aff2"><institution content-type="dept">School of Bioengineering</institution>, <institution>Dalian University of Technology</institution>, <addr-line><named-content content-type="city">Dalian</named-content></addr-line>, <country>China</country></aff><aff id="aff3"><institution content-type="dept">Cancer Stem Cell and Translational Medicine Laboratory</institution>, <institution>Shengjing Hospital of China Medical University</institution>, <addr-line><named-content content-type="city">Shenyang</named-content></addr-line>, <country>China</country></aff><aff id="aff4"><institution content-type="dept">Department of Biochemistry and Molecular Biology</institution>, <institution>Mayo Clinic</institution>, <addr-line><named-content content-type="city">Rochester</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-216782"><name><surname>Pasqualini</surname><given-names>Renata</given-names></name><role>Reviewing editor</role><aff><institution>Rutgers University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>sunlisha1224@126.com</email> (LS);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>everbright99@foxmail.com</email> (YY);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>angel-s205@163.com</email> (CL);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>14</day><month>03</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e68481</elocation-id><history><date date-type="received"><day>17</day><month>03</month><year>2021</year></date><date date-type="accepted"><day>07</day><month>03</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Zhang et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Zhang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-68481-v1.pdf"/><abstract><p><bold>Background:</bold> Integrin family are known as key gears in focal adhesion for triple-negative breast cancer (TNBC) metastasis. However, the integrin independent factor TLN1 remains vague in TNBC.</p><p><bold>Methods:</bold> Bioinformatics analysis was performed based on TCGA database and Shengjing Hospital cohort. Western blot and RT-PCR were used to detect the expression of TLN1 and integrin pathway in cells. A small-molecule C67399 was screened for blocking TLN1 and integrin β1 through a novel computational screening approach by targeting the protein-protein binding interface. Drug pharmacodynamics were determined through xenograft assay.</p><p><bold>Results:</bold> Upregulation of TLN1 in TNBC samples correlates with metastasis and worse prognosis. Silencing <italic>TLN1</italic> in TNBC cells significantly attenuated the migration of tumour cells through interfering the dynamic formation of focal adhesion with integrin β1, thus regulating FAK-AKT signal pathway and epithelial-mesenchymal transformation. Targeting the binding between TLN1 and integrin β1 by C67399 could repress metastasis of TNBC.</p><p><bold>Conclusions:</bold> TLN1 overexpression contributes to TNBC metastasis and C67399 targeting TLN1 may hold promise for TNBC treatment.</p><p><bold>Funding:</bold> This study was supported by grants from the National Natural Science Foundation of China (No. 81872159, 81902607, 81874301), Liaoning Colleges Innovative Talent Support Program (Name: Cancer Stem Cell Origin and Biological Behaviour), Outstanding Scientific Fund of Shengjing Hospital (201803) and Outstanding Young Scholars of Liaoning Province (2019-YQ-10).</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81872159</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Caigang</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Liaoning Colleges Innovative Talent Support Program</institution></institution-wrap></funding-source><award-id>Cancer Stem Cell Origin and Biological Behavior</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Caigang</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Outstanding Scientific Fund of Shengjing Hospital</institution></institution-wrap></funding-source><award-id>201803</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Caigang</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Outstanding Young Scholars of Liaoning Province</institution></institution-wrap></funding-source><award-id>2019-YQ-10</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Caigang</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81902607</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Yixiao</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81874301</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Yongliang</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Caigang Liu, Reviewing editor, <italic>eLife</italic>.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: The current study was approved by the institutional research ethics committee of Shengjing Hospital of China Medical University (Project identification code: 2018PS304K, date on 03/05/2018), and each participant signed an informed consent before being included in the study. Meanwhile, this study was performed in very strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All surgery was performed under sodium pentobarbital anesthesia, and every effort was made to minimize suffering of the animals, and all the animals were handled according to approved Animal Ethics and Experimentation Committee protocols of Shengjing Hospital of China Medical University (Project identification code: 2018PS312K, date on 03/05/2018).</p></fn><fn fn-type="other"><p>Human subjects: Written informed consent was obtained from all the patients, and this study was approved by the institutional research ethics committee of China Medical University</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><supplementary-material><ext-link xlink:href="elife-68481-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>